Merck & Company, Inc. (new) (MRK): Price and Financial Metrics


Merck & Company, Inc. (new) (MRK)

Today's Latest Price: $78.67 USD

1.16 (-1.45%)

Updated Oct 19 7:00pm

Add MRK to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MRK Stock Summary

  • MRK has a market capitalization of $201,909,314,618 -- more than approximately 99.34% of US stocks.
  • Merck & Co Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.91% of US equities in our set.
  • The volatility of Merck & Co Inc's share price is greater than that of just 0.54% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to MRK, based on their financial statements, market capitalization, and price volatility, are NVS, PFE, SAP, CSCO, and NVO.
  • Visit MRK's SEC page to see the company's official filings. To visit the company's web site, go to www.merck.com.

MRK Stock Price Chart Interactive Chart >

Price chart for MRK

MRK Price/Volume Stats

Current price $78.67 52-week high $92.64
Prev. close $79.83 52-week low $65.25
Day low $78.33 Volume 8,219,894
Day high $80.49 Avg. volume 10,659,530
50-day MA $83.17 Dividend yield 3.06%
200-day MA $80.95 Market Cap 198.98B

Merck & Company, Inc. (new) (MRK) Company Bio


Merck & Company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. The company was founded in 1891 and is based in Kenilworth, New Jersey.


MRK Latest News Stream


Event/Time News Detail
Loading, please wait...

MRK Latest Social Stream


Loading social stream, please wait...

View Full MRK Social Stream

Latest MRK News From Around the Web

Below are the latest news stories about Merck & Co Inc that investors may wish to consider to help them evaluate MRK as an investment opportunity.

Global Pneumonia Therapeutics Market Trajectory & Analytics Report 2020 Featuring Abbott Labs, Allergan, Bayer, GlaxoSmithKline, Lupin Pharma, Merck & Co, Novartis & Pfizer - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pneumonia Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Pneumonia Therapeutics Market to Reach US$22.5 Billion by the Year 2027 Amid the COVID-19 crisis, the global market for Pneumonia Therapeutics estimated at US$14.5 Billion in the year 2020, is projected to reach a revised size of US$22.5 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Drugs, one of the

Business Wire | October 2, 2020

STAT Plus: Merck’s Roger Perlmutter joins board of AI drug discovery startup Insitro

“The hardest part of drug discovery and development… is picking targets,” Perlmutter said. "And picking targets is at this point is largely an intuitive process."

STAT News | October 1, 2020

Myxoid Round Cell Liposarcoma Drug Market 2020 Emerging Players - Adaptimmune, Recordati SpA, Merck & Co., Inc, Novartis AG, Infinity Pharmaceuticals, Inc., Mirati Therapeutics, Inc

Myxoid Round Cell Liposarcoma Drug Market Research Report By Therapy (Chemotherapy, Radiation Therapy and Others), Drugs (Trabectedin, Mechlorethamine and Others), Route of Administration (Injectable, Oral), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retailers and Others),

OpenPR | October 1, 2020

Extremely Trending Report on Respiratory Drug Market over Forecast Period 2020-2025| Prominent Players Baxter, Aradigm, Roche, Merck

This report is an extensive analysis of current and potential trends in the Respiratory Drug market. The report provides an in-depth quantitative analysis of the current and future market estimations which helps to recognize the prevailing market opportunities. Key market

OpenPR | October 1, 2020

Immunohistochemistry Market To Witness Steady Growth With Danaher, Merck KGaA, Thermo Fisher Scientific, PerkinElmer, Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signalling Technology and F. Hoffmann-La Roche among others

A report by The Insight Partner's on the Immunohistochemistry Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the market

OpenPR | October 1, 2020

Read More 'MRK' Stories Here

MRK Price Returns

1-mo -8.32%
3-mo 0.45%
6-mo -0.13%
1-year -4.25%
3-year 34.61%
5-year 80.86%
YTD -11.45%
2019 22.27%
2018 39.95%
2017 -1.49%
2016 15.05%
2015 -3.89%

MRK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MRK Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8893 seconds.